[Prevalence of K-ras gene mutations in human colorectal cancers].
It has been reported that mutations in the human ras gene family convert these genes into active oncogenes. In the present study using in vitro gene amplification by the polymerase chain reaction (PCR) and mutation detection by the oligonucleotide hybridization assay, a total of 86 colorectal cancers were analyzed for the point mutations at codon 12 and 13 of K-ras genes. Mutations were present in 33 of the 86 colorectal cancers examined; 32 of the 33 mutations were at codon 12 of this gene and one of them was at codon 13. There was no apparent correlation between the presence of a ras gene mutation in a carcinoma and its anatomical location, level of differentiation, depth of invasion, degree of lymphnode metastasis or stage of progression, however, the high incidence of K-ras mutations was observed in early stage carcinomas (depth m and sm). This results support the concept that the point mutation of K-ras gene is early event in tumorigenesis of colorectal cancer.
Department of Gastroenterology, Kyoto Second Red Cross Hospital.
T
T
Hayakumo
T
T
Azuma
M
M
Nakajima
K
K
Yasuda
E
E
Cho
H
H
Mukai
Y
Y
Mizuma
T
T
Ashihara
S
S
Mizuno
S
S
Hirano
D001483:Base Sequence; D003062:Codon; D015179:Colorectal Neoplasms / Q000235:genetics*; D005260:Female; D011905:Genes, ras; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation
D003062:Codon